Abbott Laboratories $($ABT$)$ engages in the discovery, development, manufacture, and sale of a line of health care and pharmaceutical products. Below you will fund selected information from Value Line. Use the Value Line estimated $2012$ figures as the actual year$-$end figures for the company. The beta reported was $\mathrm{.}8$ and the risk$-$free rate was $3\mathrm{.}63$ percent. Assume a market risk premium of $6$ percent. Using the P$/$E$,$ P$/$CF$,$ and P$/$S ratios, estimate the $2013$ share price for Abbott Laboratories. Use the average stock price each year to calculate the price ratios. $($Do no rount intermediate calculations. Round your answers to $2$ decimal places.$)\backslash$table$[[508,09,2010,2011,012,2015,,],[1940,19\mathrm{.}82,22\mathrm{.}73,24\mathrm{.}74,25,65,21\mathrm{.}05,$Sales por sh$,3305],[4\mathrm{.}32,509,590,651,660,7\mathrm{.}30,$ripersh,$250],[303,3\mathrm{.}72,4\mathrm{.}17,4\mathrm{.}66,5\mathrm{.}00,535,$shA,$6\mathrm{.}50],[144,1\mathrm{.}60,1\mathrm{.}76,188,204,216,$per sh Be$,240],[85,70,66,95,25,\mathrm{.}75,$endilf,$90],[11\mathrm{.}48,14\mathrm{.}73,14\mathrm{.}47,1556,17\mathrm{.}05,18\mathrm{.}25,$she,$22\mathrm{.}25],[15224,1551\mathrm{.}8,1547\mathrm{.}0,1570\mathrm{.}4,15700,15600,$Commen Shs Outstg,$15500],[183,13\mathrm{.}0,122,12\mathrm{.}2,\{$

$\backslash$table$[[$Boid figures are$],[$Vekue Line$],[$estriges$]]\},$Ratio,$150],[1\mathrm{.}10,\mathrm{.}87,78,79,,1\mathrm{.}00],[26\%,3\mathrm{.}3\%,35\%,3\mathrm{.}5\%,$Yield,$26\%$